Abstract
A highly sensitive analytical method was developed to study the in vivo metabolism of paeoniflorin, one of the most principal components in traditional Chinese medicine. After hydrolyzation with sulfatase, the epimer metabolites 7S-paeonimetabolin I and 7R-paeonimetabolin I of paeoniflorin in rat plasma were successfully detected and well separated by LC–MS following picolinoyl derivatization for the first time. Borneol was used as the internal standard to quantify 7S-paeonimetabolin I and 7R-paeonimetabolin I in rat plasma. 7S-paeonimetabolin I and 7R-paeonimetabolin I show similar but different pharmacokinetic behavior. 7S-paeonimetabolin I reached the maximum mean plasma concentration of 45.7±4.6ng/mL at about 1.5h after oral administration of paeoniflorin at a dose of 5mg/kg, while 7R-paeonimetabolin I reached the maximum mean plasma concentration of 39.2±3.5ng/mL at about 1.5h. The full metabolic pathway of paeoniflorin in rats was proposed. The monoterpene compound paeoniflorin was found to be metabolized to the sulfate of 7S-paeonimetabolin I and 7R-paeonimetabolin I in vivo which maybe responsible for the pharmacological effect of paeoniflorin.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
